A Study to Evaluate the Feasibility of a High Add Multi Focal Contact Lens

Sponsor
Bausch & Lomb Incorporated (Industry)
Overall Status
Completed
CT.gov ID
NCT01518868
Collaborator
(none)
126
1
2
1
123.7

Study Details

Study Description

Brief Summary

The objective of this study is to evaluate the product performance of the investigational multifocal high add soft contact lens compared with PureVision Multi-focal contact lens on a daily wear basis.

Condition or Disease Intervention/Treatment Phase
  • Device: Investigational contact lens
  • Device: PureVision contact lens
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
126 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
A Study to Evaluate the Feasibility of a High Add Multi Focal Contact Lens
Study Start Date :
Jan 1, 2012
Actual Primary Completion Date :
Feb 1, 2012
Actual Study Completion Date :
Feb 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Investigational contact lens

multifocal high add soft contact lens

Device: Investigational contact lens
Worn on a daily wear basis for one week.

Active Comparator: PureVision contact lens

Multi-focal contact lens

Device: PureVision contact lens
Worn on a daily wear basis for one week

Outcome Measures

Primary Outcome Measures

  1. Visual Acuity [At 2 weeks follow up]

    Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).

Secondary Outcome Measures

  1. Symptoms/Complaints [At 2 weeks follow up]

    Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Have physiologically normal anterior segments

  • Be adapted wearers of soft contact lenses and wear a lens in each eye.

  • Be presbyopic and require near add correction in each eye.

  • Be an adapted monovision or multifocal contact lens wearer or be an adapted spherical lens wearer who also uses spectacles for near vision correction.

  • Have no active ocular disease or allergic conjunctivitis.

  • Must not be using any topical ocular medications.

  • Must habitually use a lens care product for lens cleaning, disinfecting, and storage.

Exclusion Criteria:
  • Any Grade 2 or greater finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.

  • Any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.

  • Anisometropia (spherical equivalent) of greater than 2.00 D.

  • Any systemic disease affecting ocular health.

  • Using any systemic or topical medications that will affect ocular physiology or lens performance.

  • Allergic to any component in the study products.

  • Ocular astigmatism of greater than 1.00 D in either eye.

  • Have had any corneal surgery (ie, refractive surgery).

  • Uses AMO Ultra Care as their habitual lens care regimen.

  • Is a toric contact lens wearer.

  • Have worn gas permeable (GP) contact lenses within last 30 days or PMMA lenses within last 3 months.

  • An active ocular disease (for example but not limited to papillary conjunctivitis, any conjunctivitis: viral, bacterial, allergic), any corneal infiltrative response or are using any ocular medications.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bausch & Lomb, Incorporated Rochester New York United States 14609

Sponsors and Collaborators

  • Bausch & Lomb Incorporated

Investigators

  • Study Director: Beverly J Barna, CCRA, Bausch & Lomb Incorporated

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bausch & Lomb Incorporated
ClinicalTrials.gov Identifier:
NCT01518868
Other Study ID Numbers:
  • 743E
First Posted:
Jan 26, 2012
Last Update Posted:
Sep 30, 2020
Last Verified:
Sep 1, 2020
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details A total of 126 participants (252 eyes) were enrolled. One-half of the participants were randomized to receive the investigational contact lens during the first crossover period, and the other half were randomized to receive the PureVision contact lens during the first crossover period. The participants crossed over to the other group at 1 week.
Pre-assignment Detail
Arm/Group Title Investigational Contact Lens Then PureVision Contact Lens PureVision Contact Lens
Arm/Group Description multifocal high add soft contact lens Investigational contact lens: Worn on a daily wear basis for one week. Multi-focal contact lens PureVision contact lens: Worn on a daily wear basis for one week Multi-focal contact lens then Investigational Contact Lens PureVision contact lens: Worn on a daily wear basis for one week multifocal high add soft contact lens Investigational contact lens: Worn on a daily wear basis for one week.
Period Title: Overall Study
STARTED 63 63
COMPLETED 59 59
NOT COMPLETED 4 4

Baseline Characteristics

Arm/Group Title Overall
Arm/Group Description Participants received both treatment groups in this cross-over study.
Overall Participants 124
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
51.6
(4.9)
Sex: Female, Male (Count of Participants)
Female
106
85.5%
Male
18
14.5%

Outcome Measures

1. Primary Outcome
Title Visual Acuity
Description Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).
Time Frame At 2 weeks follow up

Outcome Measure Data

Analysis Population Description
There were 238 eyes assessed for visual acuity for this outcome measure. Participants/eyes received both treatment groups.
Arm/Group Title Investigational Contact Lens PureVision Contact Lens
Arm/Group Description multifocal high add soft contact lens Investigational contact lens: Worn on a daily wear basis for one week. Multi-focal contact lens PureVision contact lens: Worn on a daily wear basis for one week
Measure Participants 119 119
Measure eye 238 238
Mean (Standard Deviation) [logMAR]
0.079
(0.102)
0.090
(0.091)
2. Secondary Outcome
Title Symptoms/Complaints
Description Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.
Time Frame At 2 weeks follow up

Outcome Measure Data

Analysis Population Description
There were 238 eyes assessed for symptoms/complaints for this outcome measure. Participants/eyes received both treatment groups.
Arm/Group Title Investigational Contact Lens PureVision Contact Lens
Arm/Group Description multifocal high add soft contact lens Investigational contact lens: Worn on a daily wear basis for one week. Multi-focal contact lens PureVision contact lens: Worn on a daily wear basis for one week
Measure Participants 119 119
Measure eyes 238 238
Burning/stinging upon insertion
95.6
(8.9)
92.5
(14.7)
Comfort upon insertion
89.4
(17.0)
81.5
(25.0)
Comfort at end of day
75.3
(25.4)
64.9
(28.8)
Overall comfort
81.6
(20.3)
70.5
(26.7)
Dryness
80.3
(20.3)
73.3
(26.4)
Itchiness
91.9
(13.8)
86.8
(22.1)
Redness
91.4
(14.4)
86.9
(23.0)
Distance vision
67.7
(29.8)
59.3
(30.8)
Vision at intermediate distance
80.5
(22.5)
70.3
(25.8)
Vision at near distance
65.0
(30.0)
58.8
(30.8)
Overall vision
66.7
(25.4)
56.2
(27.5)
Ease of handling/insertion
86.5
(20.4)
84.3
(21.7)
Ease of handling/removal
88.6
(16.3)
86.2
(19.6)
Overall impression
73.3
(23.5)
61.1
(29.9)

Adverse Events

Time Frame 2 weeks
Adverse Event Reporting Description Adverse events (AEs) were not coded. Therefore, source vocabulary is not applicable. A total of 126 participants (262 eyes) were assessed for AEs. Participants/eyes received both treatment groups in this cross-over study.
Arm/Group Title Investigational Contact Lens PureVision Contact Lens
Arm/Group Description multifocal high add soft contact lens Investigational contact lens: Worn on a daily wear basis by adapted monovision soft contact lens wearers for one week. Investigational contact lens: Worn on a daily wear basis by adapted multifocal soft contact wearers for one week. Investigational contact lens: Worn on a daily wear basis by adapted spherical soft contact lens wearers who may also use spectacles for near vision correction for one week Multi-focal contact lens PureVision contact lens: Worn on a daily wear basis by adapted monovision soft contact lens wearers for one week PureVision contact lens: Worn on a daily wear basis by adapted multifocal soft contact wearers for one week. PureVision contact lens: Worn on a daily wear basis by adapted spherical soft contact lens wearers who may also use spectacles for near vision correction for one week
All Cause Mortality
Investigational Contact Lens PureVision Contact Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
Investigational Contact Lens PureVision Contact Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/126 (0%) 0/126 (0%)
Other (Not Including Serious) Adverse Events
Investigational Contact Lens PureVision Contact Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/126 (0%) 0/126 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

Contact sponsor directly for details.

Results Point of Contact

Name/Title Study Director
Organization Bausch Health
Phone
Email robert.steffen@bausch.com
Responsible Party:
Bausch & Lomb Incorporated
ClinicalTrials.gov Identifier:
NCT01518868
Other Study ID Numbers:
  • 743E
First Posted:
Jan 26, 2012
Last Update Posted:
Sep 30, 2020
Last Verified:
Sep 1, 2020